We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Gábor Holló

Gábor Holló MD, PhD

Director, Glaucoma Service and Perimetry Unit, Department of Ophthalmology, Semmelweis University, Budapest, Hungary

Professor Gábor Holló is Director of the Glaucoma Service and Perimetry Unit in the Department of Ophthalmology at Semmelweis University in Budapest, Hungary. He received his MD and PhD from Semmelweis University School of Medicine, and DSc degree in the clinical and experimental investigation of the retinal nerve fibre layer and ocular blood flow in glaucoma from the Hungarian Academy of Science. Dr Holló is the recipient of several awards, including the Széchenyi Professional Award (2000–2004), and the European Glaucoma Society’s (EGS) Special Recognition Award (2003). He is a member of the European Association for Vision and Eye Research, a former Executive Committee member of the EGS, and President of the Glaucoma Section of the Hungarian Ophthalmology Society. His work for the EGS notably includes a contribution to the development of the European Diagnostic and Treatment Guidelines.

Professor Holló is a reviewer for several international ophthalmology journals and serves on the editorial boards of several scientific journals. He has edited several books and book chapters, and authored or co-authored numerous scientific peer-reviewed publications. His main research interests are in the pathogenesis, early diagnosis and medical, laser, and surgical treatment of glaucoma.

Disclosures

Serve(d) as Consultant with: Alcon

Serve(d) as Consultant with: Nicox 

Serve(d) as Consultant with: Santen